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A
 
BSTRACT
 
Cytokines are important regulatory mediators secreted
by T cells and other immunoactive cells. Based on the
cytokine synthesis patterns, CD4 T cells can often be
classified into at least two populations with different
immune regulatory functions. The Th1 cells, producing
interleukin (IL)-2 and interferon (IFN)-
 
γ
 
, are often asso-
ciated with cell-mediated immune responses such as
delayed type hypersensitivity (DTH), whereas Th2 cells,
secreting IL-4, IL-5 and IL-13, usually provide B cell
help and enhance allergic reactions. Naïve CD8
T cells, similar to CD4 T cells, can differentiate into at
least two subsets of cytolytic effector cells with distinct
cytokine patterns. The Tc1 cells secrete a Th1-like
cytokine pattern, including IL-2 and IFN-
 
γ
 
. The Tc2
cells produce Th2 cytokines, including IL-4, IL-5 and
Il-10. There is increasing evidence that Th1/Th2
and Tc1/Tc2 cytokine imbalance has been of patho-
genetic importance in various diseases, such as
allergic and autoimmune diseases. The present review
article focuses on the evidence that the imbalance of
Th1/Th2 and Tc1/Tc2 cytokines plays an important
role in various otolaryngological diseases, such as
Kimura’s disease, Wegener’s granulomatosism, acute
perceptive hearing loss and Meniere’s disease. It is
concluded that the predominance of Th1 or Th2
and Tc1 or Tc2 cells may contribute to the mechanism
in the pathogenesis of these otolaryngological
diseases.
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I
 
NTRODUCTION
 
Recent studies reported that T helper (Th) cells sub-
divided into mutually exclusive subsets: (i) Th1 cells,
which produce interleukin (IL)-2 and interferon (IFN)-
 
γ
 
;
(ii) Th2 cells, producing especially IL-4, IL-5, IL-9, IL-10
and IL-13; and (iii) cells that exhibit an unrestricted
cytokine profile (Th0).
 
1–4
 
 The Th1 cells are involved
primarily in cell-mediated immune responses, whereas
Th2 cells fulfill an important role in humoral and allergic
immune responses
 
4
 
 (Fig. 1). Similarly, CD8
 
+
 
 T cells have
recently been subdivided into CD8
 
+
 
 T cells secreting a
Th1-like cytokine pattern, which are defined as Tc1 cells,
compared with CD8
 
+
 
 T cells that secrete a Th2-like
pattern (Tc2 cells).
 
2–5
 
 A quantitative and functional
disturbance of Th1 or Th2 cells is probably important for
the pathogenesis of various otolarygological diseases;
however, studies investigating this point are rare. The
present review focuses on the evidence that the imbal-
ance of Th1/Th2 and Tc1/Tc2 cytokines plays an
important role in various otolaryngological diseases,
such as Kimura’s disease, Wegener’s granulomatosis,
acute perceptive hearing loss and Meniere’s disease.
 
W
 
EGENER
 
’
 
S
 
 
 
GRANULOMATOSIS
 
Wegener’s granulomatosis (WG) is characterized by the
classic clinicopathological features of necrotizing granu-
lomatous vasculitis involving the upper and lower res-
piratory tracts, glomerulonephritis and variable degrees of
systemic small vessel vasculitis. Necrotizing granuloma-
tous inflammation produces nasal mucosal ulceration
and saddle nose formation, tracheal inflammation etc.
The causative agent leading to granuloma formation
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remains unknown, but the presence of granulomatous
inflammation suggests T cell hyperactivity. In WG
patients, there was a strong predominance of Tc1 cells
and no significant difference was noted in the percent-
age of Th1, Th2 and Tc2 cells, which suggests that the
predominance of Tc1 cells may contribute to the mech-
anism in the pathogenesis of WG.
 
6
 
 Interferon-
 
γ
 
 and IL-4
also induce the differentiation of naïve CD8
 
+
 
 cells into
type 1 and type 2, respectively, whereas IL-12 promotes
the development of Tc1 cells.
 
7
 
 After differentiation,
effector T cells show a stable cytokine pattern and rarely,
if ever, switch to the opposite phenotype or revert to their
precursor state. However, some modifications have been
described. The Th0 cells can shift towards Th1 or Th2
in response to cytokines and human Th2 clones can
transiently express IFN-
 
γ
 
 after IL-12 treatment.
 
7–9
 
 The
Th1 cells can produce IL-4 when stimulated in the pres-
ence of IL-4.
 
9
 
 Interleukin-4 also inhibits the ability of
differentiated Tc1 cells to synthesize IL-2 and down-
regulates other functions, including cytokine synthesis,
proliferation and long-term cytotoxicity.
 
10
 
 In addition to
their classic role in the killing of infected cells, CD8
T cells play a role in the regulation of the activation and
differentiation of CD4 cells. This regulation could be
mediated through secreted products (cytokines, chemo-
kines) or by cell–cell interactions. The CD8 T cells can
alter the balance of Th1/Th2 responses 
 
in vivo
 
 by
influencing the development of IL-4- or IFN-
 
γ
 
-secreting
CD4 cells.
 
11
 
 In addition, CD8 T cells appear to play a
role in the development of CD4 perforin-mediated
cytotoxicity and have also been reported to suppress
CD4 proliferative responses through the inhibition of
costimulatory interactions.
 
12,13
 
 The CD8 cells are also
capable of influencing other components of the immune
response, such as the recruitment of eosinophils into the
lungs during respiratory syncytial virus infection or aller-
gic asthma, the activation of macrophages and the
regulation of antibody production by B cells.
 
14,15
 
 In
rheumatoid arthritis patients, there was a strong pre-
dominance of Th1 and Tc1 in synovial fluid, whereas no
major difference in cytokine production was seen in
peripheral blood.
 
16
 
 In WG, the local secretion of high
levels of IFN-
 
γ
 
 and tumor necrosis factor may represent
an important amplification loop leading to a tissue-
destructive inflammatory response.
 
17,18
 
 Interferon-
 
γ
 
 may
activate local macrophages and granulocytes to produce
 
Fig. 1
 
T helper (Th) 1 and Th2 cells. ThP, Th precursors; IL, interleukin; APC, antigen-presenting cell; IFN-
 
γ
 
, Interferon-
 
γ
 
.
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pro-inflammatory cytokines and toxic metabolites, which
cause damage to the tissue and maintain the inflam-
mation.
 
6,19
A
 
CUTE
 
 
 
SENSORINEURAL
 
 
 
HEARING
 
 
 
LOSS
 
 
 
AND
 
 
M
 
ENIERE
 
’
 
S
 
 
 
DISEASE
 
Meniere’s disease is characterized by vertigo, hearing
loss and tinnitus with episodic attacks of fluctuating
severity. Hallpike and Cairns clearly described endo-
lymphatic hydrops as the basic histopathological lesion
associated with Meniere’s disease.
 
20
 
 In 1979, McCabe
described bilateral rapidly progressive sensorineural
hearing loss (SNHL) as the first convincing autoimmune
hearing loss.
 
21
 
 Since then, many immunological studies
of SNHL have been undertaken in order to clarify its
pathogenesis. However, several conflicting results have
been reported and, as a result, the actual inner-ear
target antigen remains unclear.
 
22–25
 
 Gloddek 
 
et al
 
. also
reported an animal model that was developed by
systemic challenge with swine inner-ear protein anti-
gens.
 
26
 
 These authors have established an autoreactive
inner-ear-specific T helper cell line that is capable of
passive transfer of the disease without antigen immuni-
zation. Infiltration of T helper cells in the inner ear tissue
was observed in the transferred rats with hearing loss.
Ikezono 
 
et al
 
.
 
27
 
 have speculated that the infiltrating cells
in a labyrinth may produce various inflammatory media-
tors, such as cytokines, chemokines and eicosanoids.
These mediators can flow longitudinally into the endo-
lymphatic sac in maintaining homeostasis of the inner
ear.
 
27,28
 
 Furthermore, by studying the human temporal
bone, similar findings of focal infiltration of lymphocytes
and plasma cells in the tympanic lamellae have been
observed.
 
29
 
 These findings are both experimental and
clinical evidence for the understanding of acute low-tone
sensorineural hearing loss (ALHL) and Meniere’s disease
as cellular-mediated immune diseases of the inner ear.
The immune response appears to develop endolymphatic
hydrops associated with fluctuating hearing loss and
play an important role in some types of acute sensori-
neural hearing loss (ASHL). In patients with ASHL, there
was a strong predominance of Th1 cells and no signifi-
cant difference was noted in the percentage of Th2, Tc1
and Tc2 cells.
 
31
 
 Patients with Meniere’s disease showed
significantly increased natural killer cell activity, but not
Th1, Th2, Tc1 and Tc2 dominance.
 
31
 
 These patients had
no obvious systemic or local disease except in the inner
ear. Therefore, an abnormality of the Th1/Th2 balance
in ASHL and increased natural killer cell activity in
Meniere’s disease are thought to be related to the inner
ear disorder.
 
30,31
 
 These results are consistent with the
possibility that the etiology of ASHL and Meniere’s
disease involves an immune response.
 
K
 
IMURA
 
’
 
S
 
 
 
DISEASE
 
Kimura’s disease is a chronic granulomatous disease of
unknown etiology. It is characterized by a single or
multiple indolent tumor occurring in the subcutaneous
soft tissue, especially the parotid gland and subu-
mandibular glands, swollen lymph nodes in the neck,
marked peripheral blood eosinophilia, high serum levels
of IgE and lymph follicle proliferation with eosinophil
infiltration.
 
32–34
 
 These findings may allow us to speculate
that Th2 cells play an important role in the pathogenesis
of Kimura’s disease. In patients with Kimura’s disease,
there was a strong predominance of Th2 and Tc1 cells
and no statistically significant difference was noted in the
percentage of Th1 and Tc2 cells.
 
35
 
 These results indicate
that the predominance of Th2 and Tc1 cells may
contribute to the mechanism in the pathogenesis of
Kimura’s disease. The Th2 cells fulfilll an important role
in humoral and allergic immune responses through
the production, in particular, of IL-4, IL-5, IL-9, IL-10
and IL-13. The Th2 cells can be readily found in the late-
phase response in the lung and after intradermal injec-
tion of antigen into the skin.
 
36,37
 
 Some of the cytokines
secreted by these cells have direct pro-inflammatory
effects. Both IL-4 and IL-5 promote the recruitment and
survival of esosinophils and mast cells and augment IgE
production from B cells. Contrary to our expectation,
there was a strong predominance of Tc1 cells in patients
with Kimura’s disease.
 
35
 
 The Tc1 cells may contribute to
suppress the induction of Th2 responses and IgE produc-
tion during the induction phase through the production
of INF-
 
γ
 
38,39
 
 (Table 1). Recently, Ishimitsu 
 
et al.
 
 reported
that Th2-mediated allergic responses were suppressed
 
Table 1
 
Comparison of CD4
 
+
 
 and CD8
 
+
 
 T cell subset
effector functions
Th1 Th2 Tc1 Tc2
IgE
 
↓ ↑ ↓ ↓
 
Cytotoxic
 
↑ ↑↑ ↑↑
 
Apoptosis Low High
Survival Good Poor
Anergy Resistant Susceptible
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by the induction of Tc1 responses.
 
39
 
 Our findings
 
35
 
support the idea that Tc1 cells may augment the Th2
responses during the effector phase in Kimura’s disease.
 
C
 
ONCLUSIONS
 
An imbalance of Th1/Th2 and Tc1/Tc2 cells was
observed in various otolaryngological diseases, such as
Kimura’s disease, WG and acute perceptive hearing
loss. It is concluded that the predominance of Th1 or
Th2 and Tc1 or Tc2 cells may contribute to the mecha-
nism in the pathogenesis of these otolaryngological
diseases.
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